EHT-1610 is a novel, potent and selective DYRK kinase inhibito with IC50s of 0.22, 0.28 nM for DYRK1A and DYRK1B, respectively. DYRK1B (also known as Mirk for minibrain-related kinase) is potentially an attractive cancer target that is highly expressed in quiescent cancer cells while it is expressed at very low levels in normal tissue.

纯度：≥98%

CAS：1425945-60-3